Cullinan Oncology, Inc. (CGEM) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CGEM Hot Sheet
Join SI Premium – FREE
Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q2 EPS of ($0.75), $0.02 worse than the analyst estimate of ($0.73). Revenue for the quarter came in at $0.
For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- VIAVI launches Ultra Ethernet Transport validation tool for AI networks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
